All In MedTech

FDA Clearance Tracker · P140031-S194

SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 10, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P140031-S194
Device name
SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES
Applicant location
Irvine, CA
Received
Sep 12, 2025
Decided
Oct 10, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P140031

Device type

Device class
Class III

Every decision under product code NPT

FDA's approval statement

As written in FDA's record.

Approval of the revised protocol for the "Continued Follow-up of 'EARLY TAVR' Premarket Cohort" postapproval study ordered under P140031/S182.

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.